Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MusclePharm (MSLPQ)
OTHER OTC:MSLPQ
MusclePharm (MSLPQ) Stock Price & Analysis
20 Followers
MSLPQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.09 - $0.09
Previous Close$0.09
Volume15.00K
Average Volume (3M)N/A
Market Cap
$34.00
Enterprise Value$24.00M
Total Cash (Recent Filing)$500.00K
Total Debt (Recent Filing)$24.50M
Price to Earnings (P/E)N/A
Beta271.23
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding34,348,891
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation320.46
R-Squared0.00010
Alpha84.47
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.48
Enterprise Value/Gross Profit4.47
Enterprise Value/Ebitda-6.21
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MSLPQ FAQ
What was MusclePharm’s price range in the past 12 months?
MusclePharm lowest stock price was $0.09 and its highest was $0.09 in the past 12 months.
What is MusclePharm’s market cap?
Currently, no data Available
When is MusclePharm’s upcoming earnings report date?
MusclePharm’s upcoming earnings report date is May 13, 2024 which is in 5 days.
How were MusclePharm’s earnings last quarter?
Currently, no data Available
Is MusclePharm overvalued?
According to Wall Street analysts MusclePharm’s price is currently Overvalued.
Does MusclePharm pay dividends?
MusclePharm does not currently pay dividends.
What is MusclePharm’s EPS estimate?
MusclePharm’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MusclePharm have?
MusclePharm has 34,348,892 shares outstanding.
What happened to MusclePharm’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MusclePharm?
Currently, no hedge funds are holding shares in MSLPQ
---
Company Description
MusclePharm
MusclePharm Corp. develops, manufactures, markets, and distributes branded nutritional supplements. Its portfolio of recognized brands include MusclePharm Sport Series, Essential Series and FitMiss, as well as Natural Series. Its products include performance powders, capsules, tablets, and gels. MusclePharm provides clinically proven supplements that are developed through a six-stage research process utilizing the expertise of nutritional scientists, physicians, and universities. The company was founded by Bradley J. Pyatt and Cory J. Gregory on August 4, 2006 and is headquartered in Burbank, CA.
---
---